A citation-based method for searching scientific literature

Hugh Davis, Vanessa Jones Briscoe, Sofio Dumbadze, Stephen N Davis. Expert Opin Investig Drugs 2019
Times Cited: 4







List of co-cited articles
19 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
Katherine R Tuttle, Frank C Brosius, Sharon G Adler, Matthias Kretzler, Ravindra L Mehta, James A Tumlin, Yoshiya Tanaka, Masakazu Haneda, Jiajun Liu, Maria E Silk,[...]. Nephrol Dial Transplant 2018
82
50

Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
Melanie P Chin, George L Bakris, Geoffrey A Block, Glenn M Chertow, Angie Goldsberry, Lesley A Inker, Hiddo J L Heerspink, Megan O'Grady, Pablo E Pergola, Christoph Wanner,[...]. Am J Nephrol 2018
76
50

ASK1 Inhibitor Halts Progression of Diabetic Nephropathy in Nos3-Deficient Mice.
Greg H Tesch, Frank Y Ma, Yingjie Han, John T Liles, David G Breckenridge, David J Nikolic-Paterson. Diabetes 2015
48
50


Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L Bakris, Melanie Chin, Heidi Christ-Schmidt, Angie Goldsberry, Mark Houser, Melissa Krauth, Hiddo J Lambers Heerspink,[...]. N Engl J Med 2013
558
50

Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Linda F Fried, Nicholas Emanuele, Jane H Zhang, Mary Brophy, Todd A Conner, William Duckworth, David J Leehey, Peter A McCullough, Theresa O'Connor, Paul M Palevsky,[...]. N Engl J Med 2013
614
50


C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria.
Jan Menne, Dirk Eulberg, Diana Beyer, Matthias Baumann, Frantisek Saudek, Zsuzsanna Valkusz, Andrzej Więcek, Hermann Haller. Nephrol Dial Transplant 2017
83
50

JAK inhibition in the treatment of diabetic kidney disease.
Frank C Brosius, Katherine R Tuttle, Matthias Kretzler. Diabetologia 2016
60
50

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial.
Juan F Navarro-González, Carmen Mora-Fernández, Mercedes Muros de Fuentes, Jesús Chahin, María L Méndez, Eduardo Gallego, Manuel Macía, Nieves del Castillo, Antonio Rivero, María A Getino,[...]. J Am Soc Nephrol 2015
108
50

Effect of ruboxistaurin on albuminuria and estimated GFR in people with diabetic peripheral neuropathy: results from a randomized trial.
Katherine R Tuttle, Janet B McGill, Edward J Bastyr, Keri Kles Poi, Nazila Shahri, Pamela W Anderson. Am J Kidney Dis 2015
14
50

GLP-1 receptor agonists in diabetic kidney disease: from the patient-side to the bench-side.
Brad P Dieter, Radica Z Alicic, Katherine R Tuttle. Am J Physiol Renal Physiol 2018
19
50

Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways.
Asma S Al-Onazi, Nouf M Al-Rasheed, Hala A Attia, Nawal M Al-Rasheed, Raeesa M Ahmed, Maha A Al-Amin, Coralie Poizat. J Pharm Pharmacol 2016
15
50

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.
Dick de Zeeuw, Pirow Bekker, Elena Henkel, Christopher Hasslacher, Ioanna Gouni-Berthold, Heidrun Mehling, Antonia Potarca, Vladimir Tesar, Hiddo J Lambers Heerspink, Thomas J Schall. Lancet Diabetes Endocrinol 2015
135
50

Diabetic nephropathy: Is there a role for oxidative stress?
Manpreet K Sagoo, Luigi Gnudi. Free Radic Biol Med 2018
73
50

Diabetic kidney disease.
Merlin C Thomas, Michael Brownlee, Katalin Susztak, Kumar Sharma, Karin A M Jandeleit-Dahm, Sophia Zoungas, Peter Rossing, Per-Henrik Groop, Mark E Cooper. Nat Rev Dis Primers 2015
170
50

Role of transcription factor acetylation in diabetic kidney disease.
Ruijie Liu, Yifei Zhong, Xuezhu Li, Haibing Chen, Belinda Jim, Ming-Ming Zhou, Peter Y Chuang, John Cijiang He. Diabetes 2014
120
50

ASK1 contributes to fibrosis and dysfunction in models of kidney disease.
John T Liles, Britton K Corkey, Gregory T Notte, Grant R Budas, Eric B Lansdon, Ford Hinojosa-Kirschenbaum, Shawn S Badal, Michael Lee, Brian E Schultz, Sarah Wise,[...]. J Clin Invest 2018
52
50

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
50

The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
Juan F Navarro, Carmen Mora-Fernández. Cytokine Growth Factor Rev 2006
132
25

YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines.
Dhamodharan Umapathy, Sireesh Dornadula, Ezhilarasi Krishnamoorthy, Vairamani Mariappanadar, Vijay Viswanathan, Kunka Mohanram Ramkumar. Immunobiology 2018
9
25

Syndecans in chronic inflammatory and autoimmune diseases: Pathological insights and therapeutic opportunities.
Solomon A Agere, Eugene Y Kim, Nahid Akhtar, Salahuddin Ahmed. J Cell Physiol 2018
11
25


Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis.
Craig Leonardi, Robert Matheson, Claus Zachariae, Gregory Cameron, Linda Li, Emily Edson-Heredia, Daniel Braun, Subhashis Banerjee. N Engl J Med 2012
680
25

Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.
Marko Salmi, Sirpa Jalkanen. Antioxid Redox Signal 2019
34
25

Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation.
Yohei Ikezumi, Lynette A Hurst, Takao Masaki, Robert C Atkins, David J Nikolic-Paterson. Kidney Int 2003
112
25

High Glucose and Lipopolysaccharide Activate NOD1- RICK-NF-κB Inflammatory Signaling in Mesangial Cells.
W Huang, F Gou, Y Long, Y Li, H Feng, Q Zhang, C Gao, G Chen, Y Xu. Exp Clin Endocrinol Diabetes 2016
18
25

Leptin and NGF in saliva of patients with diabetes mellitus type 2: A pilot study.
Asta Tvarijonaviciute, Candela Castillo, Jose J Ceron, Silvia Martinez-Subiela, Fernando Tecles, Pia López-Jornet. J Oral Pathol Med 2017
10
25

NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
Pengchao Du, Baoxia Fan, Huirong Han, Junhui Zhen, Jin Shang, Xiaojie Wang, Xiang Li, Weichen Shi, Wei Tang, Chanchan Bao,[...]. Kidney Int 2013
90
25

Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
25

The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet.
Ji Hye Han, Tae Jung Oh, Ghayoung Lee, Hyo Jin Maeng, Dong Hwa Lee, Kyoung Min Kim, Sung Hee Choi, Hak Chul Jang, Hye Seung Lee, Kyong Soo Park,[...]. Diabetologia 2017
96
25

miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy.
Yan Sun, Rui Peng, Huimin Peng, Handeng Liu, Li Wen, Tianhui Wu, Hong Yi, Ailing Li, Zheng Zhang. Mol Cell Endocrinol 2016
57
25

Allelic depletion of grem1 attenuates diabetic kidney disease.
Sarah A Roxburgh, Jayesh J Kattla, Simon P Curran, Yvonne M O'Meara, Carol A Pollock, Roel Goldschmeding, Catherine Godson, Finian Martin, Derek P Brazil. Diabetes 2009
55
25

Targeting T helper 17 by mycophenolate mofetil attenuates diabetic nephropathy progression.
Su-Mi Kim, Sang-Ho Lee, Arah Lee, Dong-Jin Kim, Yang-Gyun Kim, Se-Yun Kim, Kyung-Hwan Jeong, Tae-Won Lee, Chun-Gyoo Ihm, Sung-Jig Lim,[...]. Transl Res 2015
29
25

Enhanced acute-phase response and oxidative stress in older adults with type II diabetes.
F Arnalich, A Hernanz, D López-Maderuelo, J M Peña, J Camacho, R Madero, J J Vázquez, C Montiel. Horm Metab Res 2000
53
25

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.
Iolanda Lazaro, Ainhoa Oguiza, Carlota Recio, Beñat Mallavia, Julio Madrigal-Matute, Julia Blanco, Jesus Egido, Jose-Luis Martin-Ventura, Carmen Gomez-Guerrero. Diabetes 2015
38
25

CXCR4 promotes renal tubular cell survival in male diabetic rats: implications for ligand inactivation in the human kidney.
Ferhan S Siddiqi, Li-Hao Chen, Suzanne L Advani, Kerri Thai, Sri N Batchu, Tamadher A Alghamdi, Kathryn E White, Manish M Sood, Ian W Gibson, Kim A Connelly,[...]. Endocrinology 2015
17
25

The role of the mammalian target of rapamycin (mTOR) in renal disease.
Wilfred Lieberthal, Jerrold S Levine. J Am Soc Nephrol 2009
203
25

Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats.
Vivian Soetikno, Flori R Sari, Vijayakumar Sukumaran, Arun Prasath Lakshmanan, Meilei Harima, Kenji Suzuki, Hiroshi Kawachi, Kenichi Watanabe. J Nutr Biochem 2013
66
25

The JAK-STAT pathway at twenty.
George R Stark, James E Darnell. Immunity 2012
751
25

NOD2 promotes endothelial-to-mesenchymal transition of glomerular endothelial cells via MEK/ERK signaling pathway in diabetic nephropathy.
Jin Shang, Ya Zhang, Yumin Jiang, Zhenzhen Li, Yiqi Duan, Luyao Wang, Jing Xiao, Zhanzheng Zhao. Biochem Biophys Res Commun 2017
27
25

Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis.
Oscar López-Franco, Yusuke Suzuki, Guillermo Sanjuán, Julia Blanco, Purificación Hernández-Vargas, Yoshikage Yo, Jeffrey Kopp, Jesús Egido, Carmen Gómez-Guerrero. Am J Pathol 2002
94
25


Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation.
H Sugimoto, K Shikata, K Hirata, K Akiyama, M Matsuda, M Kushiro, Y Shikata, N Miyatake, M Miyasaka, H Makino. Diabetes 1997
152
25

Dendritic cells and macrophages in the kidney: a spectrum of good and evil.
Natasha M Rogers, David A Ferenbach, Jeffrey S Isenberg, Angus W Thomson, Jeremy Hughes. Nat Rev Nephrol 2014
105
25

Association of Interleukin-6 -174G/C Polymorphism with the Risk of Diabetic Nephropathy in Type 2 Diabetes: A Meta-analysis.
Zhen-Hai Cui, Xiao-Ting Lu, Kang-Li Xiao, Yang Chen, Hui-Qing Li. Curr Med Sci 2019
7
25

The role of chemokines and chemokine receptors in diabetic nephropathy.
Christiane Ruster, Gunter Wolf. Front Biosci 2008
85
25


Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy.
Desirée Luis-Rodríguez, Alberto Martínez-Castelao, José Luis Górriz, Fernando De-Álvaro, Juan F Navarro-González. World J Diabetes 2012
67
25

Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Vanessa Marchant, Alejandra Droguett, Graciela Valderrama, M Eugenia Burgos, Daniel Carpio, Bredford Kerr, Marta Ruiz-Ortega, Jesús Egido, Sergio Mezzano. Am J Physiol Renal Physiol 2015
24
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.